Potential new therapy shows promising results in SM trial
A clinical trial assessing the efficacy of bezuclastinib in improving SM symptoms in patients with SM has shown positive mid-stage results.
A clinical trial assessing the efficacy of bezuclastinib in improving SM symptoms in patients with SM has shown positive mid-stage results.
A recent case report describes an asymptomatic patient with SM who was diagnosed after a routine colonoscopy.
A recently-published case report highlights the importance of adequate tissue sampling when evaluating for SM, researchers wrote.
New data shows over half of patients in a phase 2 study of an investigational SM therapy saw improvement in severe SM-associated symptoms.